Long-term pathological consequences of prenatal infection: Beyond brain disorders

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 1, 2015, Pages R1-R12

  Labouesse, Marie A ^a   Langhans, Wolfgang ^a   Meyer, Urs ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Autism; Cytokines; Gut Microbiota; Maternal Immune Activation; Metabolic Syndrome; Schizophrenia

Indexed keywords

ADIPOSE TISSUE; ARTICLE; BEHAVIOR DISORDER; BODY WEIGHT; BONE MARROW CELL; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DYSBIOSIS; GASTROINTESTINAL DISEASE; GLUCOSE METABOLISM; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INSULIN RESISTANCE; INTESTINE MUCOSA PERMEABILITY; INTRAUTERINE INFECTION; METABOLIC DISORDER; METABOLIC SYNDROME X; MICROFLORA; NERVE CELL DIFFERENTIATION; NONHUMAN; OBESITY; PERIPHERAL NERVOUS SYSTEM; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; AGE; ANIMAL; BACTERIUM; COMMUNICABLE DISEASE; COMPLICATION; ENERGY METABOLISM; FEMALE; GASTROINTESTINAL TRACT; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; RISK FACTOR; SIGNAL TRANSDUCTION; TIME;

AUTACOID;

ADIPOSITY; AGE FACTORS; ANIMALS; BACTERIA; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; COMMUNICABLE DISEASES; DYSBIOSIS; ENERGY METABOLISM; FEMALE; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84935502711     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00087.2015     Document Type: Article

References (160)

1. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 6: 237ra65, 2014.
2. Abazyan B, Nomura J, Kannan G, Ishizuka K, Tamashiro KL, Nucifora F, Pogorelov V, Ladenheim B, Yang C, Krasnova IN, Cadet JL, Pardo C, Mori S, Kamiya A, Vogel MW, Sawa A, Ross CA, Pletnikov MV. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68: 1172–1181.
3. Aguilar-Valles A, Flores C, Luheshi GN. Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia. PLoS One 5: e10967, 2010.
4. Aguilar-Valles A, Jung S, Poole S, Flores C, Luheshi GN. Leptin and interleukin-6 alter the function of mesolimbic dopamine neurons in a rodent model of prenatal inflammation. Psychoneuroendocrinology 37: 956–969, 2012.
5. Arsenault D, St-Amour I, Cisbani G, Rousseau LS, Cicchetti F. The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspring. Brain Behav Immun 38: 77–90, 2014.
6. Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 11: 47–55, 2006.
7. Atladóttir HO, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40: 1423–1430, 2010.
8. Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, Singh K, Waters T, Minium J, Presley L, Catalano PM, Hauguel-de Mouzon S. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 19: 476–482, 2011.
9. Bauman ML. Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics 7: 320–327, 2010.
10. 10. Baumann N, Turpin JC. Neurochemistry of stress. An overview. Neurochem Res 35: 1875–1879, 2010.
11. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141: 599–609, 2011.
12. Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85: 1–17, 2000.
13. Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J Gastro-enterol Hepatol 20: 332–339, 2005.
14. Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 3: 14, 2009.
15. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 24: 881–897, 2010.
16. Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 20: 509–518, 2014.
17. Borrell J, Vela JM, Arévalo-Martin A, Molina-Holgado E, Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychop-harmacology 26: 204–215, 2002.
18. Bronson SL, Bale TL. Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment. Endocrinology 155: 2635–2646, 2014.
19. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167: 261–280, 2010.
20. Brown LD. Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health. J Endocrinol 221: R13–R29, 2014.
21. Brown AS. The environment and susceptibility to schizophrenia. Prog Neurobiol 93: 23–58, 2011.
22. Canetta SE, Bao Y, Co MD, Ennis FA, Cruz J, Terajima M, Shen L, Kellendonk C, Schaefer CA, Brown AS. Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring. Am J Psychiatry 171: 557–563, 2014.
23. Cheung C, Yu K, Fung G, Leung M, Wong C, Li Q, Sham P, Chua S, McAlonan G. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS One 5: e12233, 2010.
24. Chow Z, Banerjee A, Hickey MJ. Controlling the fire - tissue-specific mechanisms of effector regulatory T-cell homing. Immunol Cell Biol 93: 355–363, 2015.
25. Cocoros NM, Lash TL, Nørgaard M, Farkas DK, DeMaria A Jr, Sørensen HT. Hospitalized prenatal and childhood infections and obesity in Danish male conscripts. Ann Epidemiol 23: 307–313, 2013.
26. Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011: 161358, 2011.
27. Critchley HD, Harrison NA. Visceral influences on brain and behavior. Neuron 77: 624–638, 2013.
28. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13: 701–712, 2012.
29. Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Björntorp P, Albertsson Wikland K, Holmäng A. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab 281: E326–E334, 2001.
30. Dahlgren J, Samuelsson AM, Jansson T, Holmäng A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res 60: 147–151, 2006.
31. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42: 1–8, 1997.
32. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46–56, 2008.
33. Daston GP, Overmann GJ, Baines D, Taubeneck MW, Lehman-McKeeman LD, Rogers JM, Keen CL. Altered Zn status by alpha-hederin in the pregnant rat and its relationship to adverse developmental outcome. Reprod Toxicol 8: 15–24, 1994.
34. de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37: 197–206, 2014.
35. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108: 3047–3052, 2011.
36. Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 25: 713–719.
37. Dover GJ. The Barker hypothesis: how pediatricans will diagnose and prevent common adult-onset diseases. Trans Am Clin Climatol Assoc 120: 199–207, 2009.
38. Drong AW, Lindgren CM, McCarthy MI. The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92: 707–715, 2012.
39. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91: 48–55, 2003.
40. Fernandez-Egea E, Miller B, Garcia-Rizo C, Bernardo M, Kirkpat-rick B. Metabolic effects of olanzapine in patients with newly diagnosed psychosis. J Clin Psychopharmacol 31: 154–159, 2011.
41. Freeman DJ. Effects of maternal obesity on fetal growth and body composition: implications for programming and future health. Semin Fetal Neonatal Med 15: 113–118, 2010.
42. Galvão MC, Chaves-Kirsten GP, Queiroz-Hazarbassanov N, Car-valho VM, Bernardi MM, Kirsten TB. Prenatal zinc reduces stress response in adult rat offspring exposed to lipopolysaccharide during gestation. Life Sci 120: 54–60, 2015.
43. Garay PA, Hsiao EY, Patterson PH, McAllister AK. Maternal immune activation causes age- and region-specific changes in brain cyto-kines in offspring throughout development. Brain Behav Immun 31: 54–68, 2013.
44. Giovanoli S, Engler H, Engler A, Richetto J, Voget M, Willi R, Winter C, Riva MA, Mortensen PB, Feldon J, Schedlowski M, Meyer U. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339: 1095–1099, 2013.
45. Girard S, Tremblay L, Lepage M, Sébire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol 184: 3997–4005, 2010.
46. Gittenberger-de Groot AC, Bartelings MM, Poelmann RE, Haak MC, Jongbloed MR. Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Semin Fetal Neonatal Med 18: 237–244, 2013.
47. Golub R, Cumano A. Embryonic hematopoiesis. Blood Cells Mol Dis 51: 226–231, 2013.
48. Graeber MB. Neuroinflammation: no rose by any other name. Brain Pathol 24: 620–622, 2014.
49. Haddad JJ, Saadé NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 133: 1–19, 2002.
50. Hagberg H, Gressens P, Mallard C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 71: 444–457, 2012.
51. Harvey L, Boksa P. A stereological comparison of GAD67 and reelin expression in the hippocampal stratum oriens of offspring from two mouse models of maternal inflammation during pregnancy. Neurophar-macology 62: 1767–1776, 2012.
52. Harvey L, Boksa P. Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev Neurobiol 72: 1335–1348, 2012.
53. Heald A. Physical health in schizophrenia: a challenge for antipsychotic therapy. Eur Psychiatry 25 Suppl 2: S6–S11, 2010.
54. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 299: R711–R722, 2010.
55. Hei MY, Yi ZW. Environmental factors for the development of fetal urinary malformations. World J Pediatr 10: 17–23, 2014.
56. Holmlund U, Cebers G, Dahlfors AR, Sandstedt B, Bremme K, Ekström ES, Scheynius A. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology 107: 145–151, 2002.
57. Howerton CL, Bale TL. Prenatal programing: at the intersection of maternal stress and immune activation. Horm Behav 62: 237–242, 2012.
58. Hsiao EY, McBride SW, Chow J, Mazmanian SK, Patterson PH. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci USA 109: 12,776–12,781, 2012.
59. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155: 1451–1463, 2013.
60. Huhta J, Linask KK. Environmental origins of congenital heart disease: the heart-placenta connection. Semin Fetal Neonatal Med 18: 245–250, 2013.
61. Johnson J, Anderson B, Pass RF. Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol 55: 521–530, 2012.
62. Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 12: 638–651, 2011.
63. Kirkpatrick B, Miller BJ, Garcia-Rizo C, Fernandez-Egea E, Bernardo M. Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits? Schizophr Bull 38: 280–284, 2012.
64. Kirkpatrick B, Miller BJ. Inflammation and schizophrenia. Schizophr Bull 39: 1174–1179, 2013.
65. Kluger MJ, Rothenburg BA. Fever and reduced iron: their interaction as a host defense response to bacterial infection. Science 203: 374–376, 1979.
66. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30: 620–650, 2002.
67. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: patho-physiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 62: 591–599, 2011.
68. Kovacs CS. Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev 94: 1143–1218, 2014.
69. Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C, Manalastas A, Hilfiker M, Pfister S, Schwerdel C, Riether C, Meyer U, Knuesel I. Systemic immune challenges trigger and drive Alzheimerlike neuropathology in mice. J Neuroinflammation 9: 151, 2012.
70. Kunzmann S, Collins JJ, Kuypers E, Kramer BW. Thrown off balance: the effect of antenatal inflammation on the developing lung and immune system. Am J Obstet Gynecol 208: 429–437, 2013.
71. Kwik-Uribe CL, Gietzen D, German JB, Golub MS, Keen CL. Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J Nutr 130: 2821–2830, 2000.
72. Kwik-Uribe CL, Golub MS, Keen CL. Chronic marginal iron intakes during early development in mice alter brain iron concentrations and behavior despite postnatal iron supplementation. J Nutr 130: 2040–2048, 2000.
73. Lakshmy R. Metabolic syndrome: role of maternal undernutrition and fetal programming. Rev Endocr Metab Disord 14: 229–240, 2013.
74. Lanté F, Meunier J, Guiramand J, De Jesus Ferreira MC, Cambonie G, Aimar R, Cohen-Solal C, Maurice T, Vignes M, Barbanel G. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus 18: 602–609, 2008.
75. Lanté F, Meunier J, Guiramand J, Maurice T, Cavalier M, de Jesus Ferreira MC, Aimar R, Cohen-Solal C, Vignes M, Barbanel G. Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain. Free Radic Biol Med 42: 1231–1245, 2007.
76. Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 102: 1906–1910, 2005.
77. Li M, Sloboda DM, Vickers MH. Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Exp Diabetes Res 2011: 592408, 2011.
78. Lin YL, Lin SY, Wang S. Prenatal lipopolysaccharide exposure increases anxiety-like behaviors and enhances stress-induced corticoste-rone responses in adult rats. Brain Behav Immun 26: 459–468, 2012.
79. Lipina TV, Zai C, Hlousek D, Roder JC, Wong AH. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 33: 7654– 7666, 2013.
80. Lumbers ER, Pringle KG, Wang Y, Gibson KJ. The renin-angiotensin system from conception to old age: the good, the bad and the ugly. Clin Exp Pharmacol Physiol 40: 743–752, 2013.
81. Luo ZC, Xiao L, Nuyt AM. Mechanisms of developmental programming of the metabolic syndrome and related disorders. World J Diabetes 1: 89–98, 2010.
82. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69: 1035S–1045S, 1999.
83. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26: 607–616, 2012.
84. Marques AH, Bjørke-Monsen AL, Teixeira AL, Silverman MN. Maternal stress, nutrition and physical activity: Impact on immune function, CNS development and psychopathology. Brain Res In press.
85. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 13: 453–461, 2008.
86. Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20: 440–446, 2015.
87. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34: 15,490–15,496, 2014.
88. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12: 453–466, 2011.
89. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85: 571–633, 2005.
90. Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 119: 4–14, 2009.
91. Meyer U, Engler A, Weber L, Schedlowski M, Feldon J. Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience 154: 701–709, 2008.
92. Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69: 26R–33R, 2011.
93. Meyer U, Feldon J, Fatemi SH. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurode-velopmental brain disorders. Neurosci Biobehav Rev 33: 1061–1079, 2009.
94. Meyer U, Feldon J, Schedlowski M, Yee BK. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neuro-sci Biobehav Rev 29: 913–947, 2005.
95. Meyer U, Feldon J, Yee BK. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35: 959–972, 2009.
96. Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13: 208–221, 2008.
97. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26: 4752–4762, 2006.
98. Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33: 441–456, 2008.
99. Meyer U, Yee BK, Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist 13: 241–256, 2007.
100. Meyer U. Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75: 307–315, 2014.
101. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70: 663–671, 2011.
102. Miller BJ, Culpepper N, Rapaport MH, Buckley P. Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies. Prog Neuropsychopharmacol Biol Psychiatry 42: 92–100, 2013.
103. Moreno-De-Luca A, Myers SM, Challman TD, Moreno-De-Luca D, Evans DW, Ledbetter DH. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol 12: 406–414, 2013.
104. Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci 15: 367–378, 2014.
105. Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 222: R113–R127, 2014.
106. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14–20, 2014.
107. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97: 8841–8848, 2000.
108. Naviaux JC, Schuchbauer MA, Li K, Wang L, Risbrough VB, Powell SB, Naviaux RK. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Transl Psychiatry 4: e400, 2014.
109. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271–1276, 2007.
110. Niklasson B, Samsioe A, Blixt M, Sandler S, Sjöholm A, Lagerquist E, Lernmark A, Klitz W. Prenatal viral exposure followed by adult stress produces glucose intolerance in a mouse model. Diabetologia 49: 2192–2129, 2006.
111. Nilsson C, Larsson BM, Jennische E, Eriksson E, Björntorp P, York DA, Holmäng A. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring. Endocrinology 142: 2622–2630, 2001.
112. Onore CE, Schwartzer JJ, Careaga M, Berman RF, Ashwood P. Maternal immune activation leads to activated inflammatory macro-phages in offspring. Brain Behav Immun 38: 220–226, 2014.
113. Owen MJ. Intellectual disability and major psychiatric disorders: A continuum of neurodevelopmental causality. Br J Psychiatry 200: 268–269, 2012.
114. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevel-opmental animal model of schizophrenia. Biol Psychiatry 59: 546–554, 2006.
115. Pacheco-López G, Giovanoli S, Langhans W, Meyer U. Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. Schizophr Bull 39: 319–329, 2013.
116. Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS. Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 70: 677–685, 2013.
117. Patterson PH. Maternal infection and immune involvement in autism. Trends Mol Med 17: 389–394, 2011.
118. Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex— linking immunity and metabolism. Nat Rev Endocrinol 8: 743–754, 2012.
119. Pineda E, Shin D, You SJ, Auvin S, Sankar R, Mazarati A. Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann Neurol 74: 11–19, 2013.
120. Pongratz G, Straub RH. Role of peripheral nerve fibres in acute and chronic inflammation in arthritis. Nat Rev Rheumatol 9: 117–126, 2013.
121. Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L, Cata-lano P, Hauguel-de Mouzon S. Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig 13: 53–57, 2006.
122. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27: 119–145, 2009.
123. Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism—a current review of clinical and animal studies. Neurotoxicol Teratol 36: 47–56, 2013.
124. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160: 284–289, 2003.
125. Salamone JD, Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron 76: 470–485, 2012.
126. Salisbury AM, Begon M, Dove W, Niklasson B, Stewart JP. Ljungan virus is endemic in rodents in the UK. Arch Virol 159: 547–551, 2014.
127. Sanders TR, Kim DW, Glendining KA, Jasoni CL. Maternal obesity and IL-6 lead to aberrant developmental gene expression and deregulated neurite growth in the fetal arcuate nucleus. Endocrinology 155: 2566–2577, 2014.
128. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 174: 992–1002, 2005.
129. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404: 661–671, 2000.
130. Seckl JR, Holmes MC. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal ‘programming’ of adult pathophysiology. Nat Clin Pract Endocrinol Metab 3: 479–488, 2007.
131. Sell H, Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 13: 366–370, 2010.
132. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191–1197, 2005.
133. Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res In press.
134. Shields RW. Functional anatomy of the autonomic nervous system. J Clin Neurophysiol 10: 2–13, 1993.
135. Shimogori T, Lee DA, Miranda-Angulo A, Yang Y, Wang H, Jiang L, Yoshida AC, Kataoka A, Mashiko H, Avetisyan M, Qi L, Qian J, Blackshaw S. A genomic atlas of mouse hypothalamic development. Nat Neurosci 13: 767–775, 2010.
136. Short DD, Hawley JM, McCarthy MF. Management of schizophrenia with medical disorders: cardiovascular, pulmonary, and gastrointestinal. Psychiatr Clin North Am 32: 759–773, 2009.
137. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27: 10,695–10,702, 20107.
138. Smoller W, Craddock N, Kendler K, Lee PH, Neale BM, Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381: 1371–1379, 2013.
139. Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsy-chotic treatment or cardiometabolic risk? Acta Psychiatr Scand 119: 171–179, 2009.
140. Symonds ME, Mostyn A, Pearce S, Budge H, Stephenson T. Endocrine and nutritional regulation of fetal adipose tissue development. J Endocrinol 179: 293–299, 2003.
141. Symonds ME, Sebert SP, Hyatt MA, Budge H. Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol 5: 604–610.
142. Taubeneck MW, Daston GP, Rogers JM, Gershwin ME, Ansari A, Keen CL. Tumor necrosis factor-alpha alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. J Nutr 125: 908–919, 1995.
143. Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 26: 137–141, 2002.
144. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 121: 2126–2132, 2011.
145. Tracey KJ. The inflammatory reflex. Nature 420: 853–859, 2002.
146. Traynor TR, Majde JA, Bohnet SG, Krueger JM. Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Life Sci 74: 2563–2576, 2004.
147. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs, and the LPS-activation cluster. Trends Immunol 23: 301–304, 2002.
148. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799–809, 2009.
149. Unger EL, Paul T, Murray-Kolb LE, Felt B, Jones BC, Beard JL. Early iron deficiency alters sensorimotor development and brain mono-amines in rats. J Nutr 137: 118–124, 2007.
150. Upthegrove R, Manzanares-Teson N, Barnes NM. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 155: 101–108, 2014.
151. Urakubo A, Jarskog LF, Lieberman JA, Gilmore JH. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 47: 27–36, 2001.
152. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 73: 79–118.
153. Verma SK, Subramaniam M, Liew A, Poon LY. Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry 70: 997–1000, 2009.
154. 154. Vuillermot S, Joodmardi E, Perlmann T, Ögren SO, Feldon J, Meyer U. Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. J Neurosci 32: 436-451, 2012.
155. Vuillermot S, Weber L, Feldon J, Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 30: 1270-1287, 2010.
156. Welberg LA, Seckl JR. Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 13: 113-128, 2001.
157. Willi R, Harmeier A, Giovanoli S, Meyer U. Altered GSK3(3 signaling in an infection-based mouse model of developmental neuropsychiatric disease. Neuropharmacology 73: 56-65.
158. Zager A, Andersen ML, Tufik S, Palermo-Neto J. Maternal immune activation increases the corticosterone response to acute stress without affecting the hypothalamic monoamine content and sleep patterns in male mice offspring. Neuroimmunomodulation 21: 37–44, 2014.
159. Zaretsky MV, Alexander JM, Byrd W, Bawdon RE. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 103: 546–550, 2004.
160. Zuckerman L, Rehavi M, Nachman R, Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28: 1778–1789, 2003.